IC-600

N/A

Report date: 2023/05/22 10:19:13

Base Information

Drug NameIC-600
Drug Alias NameIC-600
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionApoptosis-associated speck-like protein containing a CARD inhibitors
TargetsInflammasomesApoptosis-associated speck-like protein containing a CARD
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZyVersa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZyVersa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A